You are here: Home » Reuters » News
Business Standard

Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services


By Bill Berkrot and Natalie Grover(Reuters) - Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV, a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry.The offer price of $35 per share represents a premium of about 35 percent to Patheon's Friday close. Thermo will also assume $2 billion in net debt, putting the cost of the deal at about $7.2 billion for Patheon, which generated $1.9 billion in revenue last year.Thermo Fisher, the world's largest maker of scientific ...

This article is no longer available in our repository.

There could be multiple reasons for this.